France's BioProtein Technologies, a biotechnology company
specialising in the production of therapeutic proteins in the milk
of transgenic rabbits, has extended its biomanufacturing services
to include recombinant vaccine production.
Baxter Healthcare and GlycoFi have entered into a two-year research
collaboration under which Baxter will evaluate the potential of
using the latter firm's fungal expression platform for the
production of human therapeutic proteins....
Engineers in the US are one step closer to mass-producing
therapeutic proteins needed by today's pharmaceutical industry.
Researchers claim to have achieved a major milestone in their
efforts to effectively produce human therapeutics...